WallStSmart
VNDA

Vanda Pharmaceuticals Inc

NASDAQ: VNDA · HEALTHCARE · BIOTECHNOLOGY

$7.10
+0.71% today

Updated 2026-04-30

Market cap
$411.32M
P/E ratio
P/S ratio
1.90x
EPS (TTM)
$-3.74
Dividend yield
52W range
$4 – $10
Volume
2.8M

WallStSmart proprietary scores

39
out of 100
Grade: D
Sell
Investment rating
3.3
Growth
D
5.0
Quality
C+
2.0
Profitability
F
6.3
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$15.50
+118.31%
12-Month target
Intrinsic (DCF)
$40.21
Margin of safety
+84.78%
0 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ 84.78% below intrinsic value
Risks
- Thin margins at -102.00%
- Negative free cash flow $-29.52M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$254.38M$192.64M$198.77M$216.10M$216.10M
Net income$6.28M$2.51M$-18.90M$-220.47M$-141.19M
EPS$-3.74
Free cash flow$31.30M$12.42M$-16.25M$-110.44M$-29.52M
Profit margin2.47%1.30%-9.51%-102.02%-102.00%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
VNDA$411.32M393.32.06.35.0+84.78%Hold
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Vanda Pharmaceuticals Inc trades at $7.10. Our Smart Value Score of 39/100 indicates the stock is weak. TTM revenue stands at $216.10M. with profit margins at -102.00%. Our DCF model estimates intrinsic value at $40.21.

Frequently asked questions

What is Vanda Pharmaceuticals Inc's stock price?
Vanda Pharmaceuticals Inc (VNDA) trades at $7.10.
Is Vanda Pharmaceuticals Inc overvalued?
Smart Value Score 39/100 (Grade D, Sell). DCF value $40.21.
What is the price target of Vanda Pharmaceuticals Inc (VNDA)?
The analyst target price is $15.50, representing +118.3% upside from the current price of $7.10.
What is the intrinsic value of Vanda Pharmaceuticals Inc (VNDA)?
Based on our DCF model, intrinsic value is $40.21, a +84.8% margin of safety versus $7.10.
What is Vanda Pharmaceuticals Inc's revenue?
TTM revenue is $216.10M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio1.90x
ROE-50.90%
Beta0.71
50D MA$7.53
200D MA$6.07
Shares out0.06B
Float0.05B
Short ratio
Avg volume2.8M

Performance

1 week+0.15%
1 month+2.86%
3 months-11.05%
YTD-22.45%
1 year
3 years
5 years